MEDICA Newsletter
Social Media
More about…
- 3D printing
- Age
- Alzheimer's
- Antibiotics
- Artificial intelligence
- Baby
- Biochip
- Biocompatible
- Biomarker
- Biotechnology
- Birth
- Blood
- Brain
- Brain Tumour
- Breast
- CT
- Cancer
- Cardiovascular
- Care
- Cells
- Communication
- Dementia
- Depression
- Devices
- Diabetes
- Diagnostics
- Disinfection
- Drugs
- EEG
- Elderly Persons
- Emergency Medicine
- Environment
- Epilepsy
- Eyes
- Fitness
- Gastro
- Genetic Material
- Genetics
- Global Health
- Gynecology
- Health Care Politics
- Heart
- Hospital
- Hospital information systems
- Hygiene
- Imaging
- Immune System
- Implants
- Incontinence
- Infectious Disease
- Information Technology
- Intensive Medicine
- Intestine
- Kidney
- Knee
- Laboratory
- Laser
- Liver
- Lung
- MEDICA 2022
- MRI
- Mammography
- Materials
- Media
- Medical Apps
- Medical Markets
- Men
- Microsystems Technology
- Minimal Invasive
- Multiple Sclerosis
- Nanotechnology
- Neurology
- Optical Technologies
- Optimisation
- Organs
- Orthopedics
- Pain
- Pathogens
- Pathology
- Patients
- Pediatrics
- Personalized Medicine
- Physiotherapy
- Polymers
- Pregnancy
- Prevention
- Prostate
- Psychology
- Quality
- Radiology
- Regenerative Medicine
- Rehabilitation
- Research
- Risks
- Robotics
- SARS-CoV-2/COVID-19
- Safety
- Screening
- Screening
- Senses
- Sepsis
- Skin
- Smart textiles
- Software
- Sports
- Stem Cells
- Stents
- Sterilisation
- Stroke
- Surgery
- Surgery
- Telemedicine
- Therapy
- Tissue Engineering
- Transplantation
- Treatment
- Tuberculosis
- Ultrasound
- Virtual Reality
- Wearable technologies
- Women
- Wound Healing
- X-ray devices
BIH/David Ausserhofer
ERC Starting Grant: Why do blood and lymphatic vessels grow unchecked?
02/12/2022
Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date, little is known about the causes, which means the diagnostic and treatment options are very limited. René Hägerling of the BIH Center for Regenerative Therapies has made it his mission to remedy this.
ktsimage
Sinonasal cancer: AI facilitates breakthrough in diagnostics
30/11/2022
Researchers at LMU and Charité hospital in Berlin have developed a method for classifying difficult-to-diagnose nasal cavity tumors.
Polygraph Design
How genes and small molecules influence personal disease risk
25/11/2022
In an international collaboration with partners from Cambridge (UK), scientists from the Berlin Institute of Health at the Charité (BIH) have now discovered more than 300 regions in the genome that contribute to this individual chemical fingerprint. They have now published their results in Nature Medicine.
RCSI University of Medicine and Health Sciences
Genomic Data Infrastructure Ireland project to support discovery of genetic disease causes
24/11/2022
RCSI University of Medicine and Health Sciences and FutureNeuro are co-leading, with University College Dublin, the Irish element of a new EU project to support the integration of genomics into healthcare and advance new treatments for patients.
mahirkart
Rare cancers: early detection of hereditary cancer risk
31/10/2022
Hereditary genetic mutations play an important role in oncogenesis, but they usually remain undetected.
prostooleh
New initiative to INDICATE cancer risks
28/10/2022
INDICATE, an international collaborative initiative to unravel the role of the Human Leukocyte Antigen type as risk modifier in individuals with a genetic cancer predisposition.
sommthink/Shutterstock
Head and neck cancer: Markers to facilitate better treatment in the future
27/10/2022
Malignant tumours in the head and neck region are very heterogeneous and therefore difficult to treat. A joint study by MedUni Vienna and the Christian Doppler Laboratory for Applied Metabolomics focused on the development and identification of specific markers to improve risk assessment for patients.
Yakov_Oskanov
Using AI during cancer-screening results in more recommended controls
28/09/2022
Patients with polyps have a higher risk of evolving cancer in the future. Using Artificial intelligence (AI) during colonoscopy can be useful to detect pre-cancerous polyps, Yuichi Mori, doctor and associate professor from the Clinical Effectiveness Research group at the University of Oslo says.
DC_Studio
Project GLADIATOR - New technologies for cancer monitoring and therapy
21/09/2022
The Fraunhofer Institute for Biomedical Engineering IBMT is contributing its expertise in the field of medical biotechnology and ultrasound to an EC project to work on the next generation of theranostics for brain pathologies using autonomous externally controllable nanonetworks.
ktsimage
Ten new risk genes for Crohn's disease
20/09/2022
The results of the international study involving the Cluster of Excellence PMI also point to a previously unknown process in the development of this chronic inflammatory bowel disease.
4.0/Finci, I. et al.
Personalised antibiotic treatment strategies for tuberculosis patients
16/09/2022
In an international study presented in the journal Lancet Microbe, DZIF researchers have now succeeded in identifying patient-specific resistance patterns using a bacterial genome analysis technique.
European Society for Medical Oncology
New era of early cancer detection with blood test
14/09/2022
New data supporting the accuracy of multi-cancer early detection (MCED) blood testing, have major implications for future cancer care provision.
ckstockphoto
Machine learning to unlock genomic code in clinical cancer samples
13/09/2022
A new paper from University of Helsinki, published in Nature Communications, suggests a method for accurately analysing genomics data in cancer archival biopsies.
Prostock-studio
Genetic testing before pregnancy detects up to half of risk
08/09/2022
In the USA, doctors recommend that couples have genetic screening before trying to conceive. Researchers at the University of Zurich have now shown that a maximal variant of this test detects the risk in 44 percent of couples who are related by blood, and in just 5 percent of other couples.
Last-resort antibiotics: "We can identify carbapenemases within half an hour"
01/08/2019
Antibiotic resistance is modern medicine's greatest challenge. Some bacteria only respond to a handful of antibiotics, prompting hospitals to spend a lot of time finding an effective drug. That’s why it is critical for physicians to rapidly identify antibiotic resistance to avoid ineffective treatments.